CNCE   $8.37  0.24% Market Closed

Concert Pharmaceuticals Inc
Last Events:

2023-03-29 Trend pattern changed from нисходящий треугольник to восходящий клин.

2023-03-29 Signal in Stochastic changed from bullish recovery to bearish. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: entry into the oversold zone.

2023-03-29 Signal in MACD changed from bullish to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

2023-03-29 Trend Power changed from slow to medium strength.

2023-03-29 Trend pattern changed from восходящий клин to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bearish to bullish recovery. The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bearish reversal to bullish. Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: entrance to the overbought zone.

2023-03-29 Trend Power changed from medium strength to slow.


Current temperature: 0.91
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 6.42
Target: 13.00
High with 50% probability: 11.61
Analyst Recommendations:
Number of estimates 2
Target Price Mean 13.00
Mean unverified/preliminary 13.00 / 13.00
Target Price Low / High 9.00 / 17.00
Median / STD DEV 13.00 / 5.66
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi Sell Sell ActivelyBuy
macd Sell ActivelyBuy -
stoch ActivelyBuy ActivelyBuy -
ma20 - - -
ma50 - - -
ma100 ActivelyBuy - -
Candlestick PatternFeb. 23, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US2060221056
ceo Dr. Roger D. Tung Ph.D.
Website https://www.concertpharma.com
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of March 6, 2023, Concert Pharmaceuticals, Inc. operates as a subsidiary of Sun Pharmaceutical Industries Limited.